Submissions received: Regulation of autologous stem cell therapies The TGA sought comments from interested parties on Regulation of autologous stem cell therapies, regarding whether the regulation applied to some autologous cells is appropriate, in a consultation that closed on 3 March 2015. A total of 80 submissions were received. Of the submissions 14 from professional bodies, 12 from researchers, institutions or hospitals, 4 from industry groups, 4 from consumer groups, 20 from manufacturers, suppliers or health practitioners providing autologous stem cell therapies (businesses), 21 from patients and 5 from government bodies or other stakeholders. All submissions that were not marked as confidential are now available below in PDF format.
Nanotechnology journal Nanotechnology is essential reading for anyone who is interested in the latest advances in nanoscale science and technology. It encompasses the understanding of the fundamental physics, chemistry, biology and technology of nanometre-scale objects and how such objects can be used in the areas of computation, sensors, nanostructured materials and nano-biotechnology. Embryo editing sparks epic debate Yorgos Nikas/SPL Human embryos are at the centre of a debate over the ethics of gene editing. In a world first, Chinese scientists have reported that they have used powerful gene-editing techniques to modify human embryos. Their paper1, published in the Beijing-based journal Protein & Cell on 18 April, came as no surprise to the scientific community, but it has ignited a wide-ranging debate about what types of gene-editing research are ethical.
Brunel Institute for Bioengineering Brunel Institute for BioengineeringWe are a multidisciplinary research institute with interests in solutions for health, medicine and surgery. Follow the links to find our more about our current research involvements. Surgical Tools Robotic technology in surgical therapy has demonstrated accurate and consistent tool trajectories in contrast with manual intervention. Bioprocess EngineeringNew centrifugal liquid-liquid extraction technology was developed in the Institute’s Advanced Bioprocessing Centre. Assistive TechnologyWe design products that thoughtfully use technology to help people live better.
Gene-editing summit supports some research in human embryos Feng Zhang, a synthetic biologist at the Massachusetts Institute of Technology who develops gene-editing technology, speaks at the summit. Gene-editing technology should not be used to modify human embryos that are intended for use in establishing a pregnancy, an international summit declared in a statement issued on 3 December. The International Summit on Human Gene Editing also called for cautious development of medical applications that cannot be passed on to offspring — such as correction of the mutations that cause sickle-cell disease or modification of immune cells to target cancer. But the summit statement, authored by a 12-member organizing committee, cautioned that many technical and ethical issues should be settled before anyone attempts ‘germline’ editing — the deletion of a gene prenatally in an effort to erase an inherited disease from an embryo and prevent it from being passed on to future generations.
Royal Aeronautical Society The Aeronautical Journal is the world’s longest continuously-produced aeronautics journal and has for over a century been the UK's leading scientific and technical aeronautical journal. Published monthly, The Aeronautical Journal provides a forum for authors from the UK and overseas, academia, research establishments and industry, and acts as a platform for presenting work and research to an international audience. Each paper has been thoroughly refereed by a renowned international team of Associate Editors and reviewers, all of whom are respected experts in their field. Relevant book reviews are also published in The Aeronautical Journal. All Aeronautical Journal papers published since March 2003 can be viewed and downloaded for free by subscribers here.
Where in the world could the first CRISPR baby be born? They are meeting in China; they are meeting in the United Kingdom; and they met in the United States last week. Around the world, scientists are gathering to discuss the promise and perils of editing the genome of a human embryo. Should it be allowed — and if so, under what circumstances? The meetings have been prompted by an explosion of interest in the powerful technology known as CRISPR/Cas9, which has brought unprecedented ease and precision to genetic engineering. This tool, and others like it, could be used to manipulate the DNA of embryos in a dish to learn about the earliest stages of human development.
Technology in Medicine Section We are very keen to enhance our Section Council with new active members who have a particular interest in technology in medicine. For further information, please contact firstname.lastname@example.org or by phone on 0207 290 3934. About this section Statement of Task, International Summit on Human Gene Editing, Dec. 1-3, 2015 International Summit on Human Gene Editing Statement of Task and Planning Committee The National Academy of Sciences, National Academy of Medicine, Chinese Academy of Sciences, and the Royal Society of the UK will organize an International Summit in Washington, D.C., in December 2015 on recent scientific developments in human gene editing and the range of ethical and governance issues associated with these advances. The meeting will consider issues such as the current state of the science and available technologies; the rationale(s) for and potential benefits and risks inherent in conducting such research and in potential applications; existing (as well as potentially needed) regulatory principles, standards, or guidance for such research and potential applications; ethical concerns; legal considerations; and ways to engage critical stakeholders. An ad hoc committee will organize the meeting as well as commission papers to inform the discussions. Paul Berg, Robert W. and Vivian K.
Frequently Asked Questions How do I get into Medical Physics or Biomedical Engineering? How can I find out about training for this career? Is the training the same in each country of the United Kingdom? England The Scientist Training Programme (STP) for Medical Physicists and Biomedical Engineers in England is supported and facilitated by the National School for Healthcare Scientists.